Comparing the effect of saffron extract with methylphenidate in hyperactivity disorder

Phase 2

Recruiting

• Conditions: Attention deficit hyperactivity disorder (ADHD).; Attention-deficit hyperactivity disorder, unspecified type; F90.9

• Registration Number: IRCT20101130005280N63
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 January 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Age range between 6-12 years
Diagnosis of attention deficit hyperactivity disorder based on DSM-5 criteria
Informed parental consent
IQ in the normal range (based on interviews and previous records)
Not having a clear organic disease (based on the history obtained from the patient's family)
Not suffering from other psychiatric disorders (based on a structured interview conducted by a specialist in child and adolescent psychiatry)

Exclusion Criteria

Suffering from any type of systemic or psychiatric disease or other psychiatric disorders that require medication
Impossibility of examining the patient carefully due to unavailability
Substance dependence

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Impulsivity score. Timepoint: At the beginning of the study and 6 weeks later. Method of measurement: by Connors parent questionnaire to evaluate attention deficit hyperactivity disorder.;Attention deficit score. Timepoint: At the beginning of the study and 6 weeks later. Method of measurement: by Connors parent questionnaire to evaluate attention deficit hyperactivity disorder.